Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Performance Status”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT02102919
What this trial is testing

Innovative Training Program for Elderly in Need of Care Individuals

Who this might be right for
Poor Performance StatusMuscle Weakness
Bern University of Applied Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT00526643
What this trial is testing

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Institute, Naples 57
Testing effectiveness (Phase 2)Looking for participantsNCT07803848
What this trial is testing

Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status

Who this might be right for
Small-cell Lung Cancer
AIO-Studien-gGmbH 57
Not applicableStudy completedNCT02332083
What this trial is testing

Innovative Training Program for Elderly in Need of Care

Who this might be right for
Poor Performance StatusCognition - Other
Bern University of Applied Sciences 17
Not applicableStudy completedNCT01704976
What this trial is testing

SR-WBV Training for Frail Elderly in the Skilling up Stage

Who this might be right for
Poor Performance StatusMuscle Weakness
Bern University of Applied Sciences 27
Not applicableUnknownNCT01882335
What this trial is testing

Saving Brain in Uganda and Burkina Faso

Who this might be right for
Poor Performance StatusNeurologic DeficitsMixed Behavior and Emotional Disorder+2 more
Makerere University 600
Not applicableStudy completedNCT01713790
What this trial is testing

Innovative Training Methods for Frail Elderly in the Training Gain Stage

Who this might be right for
Poor Performance Status
Bern University of Applied Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04108026
What this trial is testing

Immunotherapy in Patient With Poor General Condition

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Intergroupe Francophone de Cancerologie Thoracique 50
Not applicableStudy completedNCT03623334
What this trial is testing

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 55
Not applicableStudy completedNCT02160873
What this trial is testing

Nighttime Feeding and Morning Endurance Performance

Who this might be right for
Poor Performance Status
Florida State University 12
Testing effectiveness (Phase 2)Study completedNCT00193336
What this trial is testing

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 60
Large-scale testing (Phase 3)Study completedNCT00040885
What this trial is testing

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Who this might be right for
AnorexiaCachexiaFatigue+1 more
Alliance for Clinical Trials in Oncology 67
Not applicableUnknownNCT01388127
What this trial is testing

Minocycline Treatment in Acute Hemorrhagic Stroke

Who this might be right for
Poor Performance Status
Wolfson Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT00006259
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Case Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT01676558
What this trial is testing

A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma
Korea Cancer Center Hospital 24
Testing effectiveness (Phase 2)UnknownNCT00580359
What this trial is testing

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
National Cancer Center, Korea 96
Testing effectiveness (Phase 2)WithdrawnNCT04262869
What this trial is testing

Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8+2 more
Emory University
Early research (Phase 1)UnknownNCT05826483
What this trial is testing

Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status

Who this might be right for
Malignant Tumor of LungPoor Performance Status
Guangzhou Institute of Respiratory Disease 20
Early research (Phase 1)Study completedNCT00986297
What this trial is testing

Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 60
Not applicableStudy completedNCT00336258
What this trial is testing

US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status

Who this might be right for
Deep Vein ThrombosisCancer
Rambam Health Care Campus 100
Next Page